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H9N2 Avian influenza virus has repeatedly infected humans and other mammals, which
highlights the need to determine the pathogenicity and the corresponding mechanism
of this virus for mammals. In this study, we found two H9N2 viruses with similar genetic
background but with different pathogenicity in mice. The A/duck/Nanjing/06/2003
(NJ06) virus was highly pathogenic for mice, with a 50% mouse lethal dose (MLD50) of
102.83 50% egg infectious dose (EID50), whereas the A/duck/Nanjing/01/1999 (NJ01)
virus was low pathogenic for mice, with a MLD 6.8150 of >10 EID50. Further studies
showed that the NJ06 virus grew faster and reached significantly higher titers than
NJ01 in vivo and in vitro. Moreover, the NJ06 virus induced more severe lung lesions,
and higher levels of inflammatory cellular infiltration and cytokine response in lungs
than NJ01 did. However, only 12 different amino acid residues (HA-K157E, NA-A9T,
NA-R435K, PB2-T149P, PB2-K627E, PB1-R187K, PA-L548M, PA-M550L, NP-G127E,
NP-P277H, NP-D340N, NS1-D171N) were found between the two viruses, and all
these residues except for NA-R435K were located in the known functional regions
involved in interaction of viral proteins or between the virus and host factors. Summary,
our results suggest that multiple amino acid differences may be responsible for the
higher pathogenicity of the NJ06 virus for mice, resulting in lethal infection, enhanced
viral replication, severe lung lesions, and excessive inflammatory cellular infiltration and
cytokine response in lungs. These observations will be helpful for better understanding
the pathogenic potential and the corresponding molecular basis of H9N2 viruses that
might pose threats to human health in the future.
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INTRODUCTION
Avian influenza A viruses (AIVs) of the H9N2 subtype were first detected in turkeys in the United
States in 1966 (Homme and Easterday, 1970), and have been circulating worldwide in multiple
avian species and endemic in poultry populations across Eurasia (Alexander, 2000, 2007; Perk
et al., 2006; Bi et al., 2010; Fusaro et al., 2011). Of note, H9N2 viruses in poultry have occasionally
been transmitted to humans and other mammals (Peiris et al., 2001; Butt et al., 2005, 2010;
Frontiers in Microbiology | www.frontiersin.org 1 November 2016 | Volume 7 | Article 1737
fmicb-07-01737 November 4, 2016 Time: 13:45 # 2
Liu et al. Pathogenicity of H9N2 AIVs in Mice
Sun et al., 2013), such as pigs and dogs, since this subtype
was first reported to be detected in patients with influenza-like
illness in Guangdong Province and in pigs in Hong Kong of
China in 1998 (Guo et al., 1999; Lin et al., 2000; Peiris et al.,
2001). In fact, follow-up serological surveys suggest that the
incidence of human infections with H9N2 viruses might be more
prevalent than what has been reported and possible human-to-
human transmission cannot be completely excluded (Butt et al.,
2005; Jia et al., 2008; Wang et al., 2009; Panwen et al., 2012).
Clinically, human H9N2 infections present as typical seasonal
influenza infections that can easily be overlooked (Lin et al., 2000;
Butt et al., 2005), providing the viruses a greater opportunity to
adapt to humans. These observations raise concerns about the
possibility that H9N2 viruses might increase pathogenicity and
transmissibility in humans. It is therefore important to investigate
the pathogenicity and the corresponding mechanism of H9N2
viruses for mammals.
Previous studies revealed that some H9N2 viruses isolated
from land-based poultry have demonstrated increased
virulence for mammals. Guo et al. (2000) reported that the
A/Chicken/Hong Kong/G9/97 and A/Quail/Hong Kong/G1/97
viruses could cause the deaths of three and two of the eight
tested mice, respectively, at a dose of 106 50% egg infectious
dose (EID50) in mice, while Lu et al. reported that the two
viruses are not lethal for mice at the same dose (Choi et al.,
2004). In another study, Li et al analyzed 27 representative H9N2
viruses isolated from chickens and ducks in Mainland China,
and found that some chicken isolates were able to replicate in
mouse lungs efficiently and could induce a 10–20% weight loss
of the inoculated mice, but none of the viruses are lethal for
mice (Li et al., 2005). However, in 2007–2009, Bi et al. (2010)
isolated six H9N2 viruses from chickens in northern China
and found that these viruses could cause 50–85.7% mortality
in mice at a dose of 106 EID50. In addition, an H9N2 virus
isolated from guinea fowl also showed enhanced replication
and efficient transmission by direct contact in a ferret model
(Wan et al., 2008). Although all these viruses cause death in
mice at a high dose, none of the viruses are highly pathogenic
for mice according to the criteria that a highly pathogenic
virus has a 50% mouse lethal dose (MLD50) value less than
103.0 EID50 (Katz et al., 2000). However, several experimental
evolutions by serial passage in mouse lungs showed that
non-lethal H9N2 isolates could evolve to be lethal or highly
pathogenic for mice after serial passage in mouse lungs (Zhang
et al., 2011; Wang et al., 2012; Liu et al., 2014). Therefore, it
is necessary to investigate the pathogenic potential and the
corresponding molecular basis of H9N2 avian influenza viruses
in mammals.
Several molecular determinants have already been
identified that govern the pathogenicity of avian influenza
virus for mammals, such as amino acid substitutions in
the ribonucleoprotein (RNP) complex (Gabriel et al., 2005;
Salomon et al., 2006; Song et al., 2009; Sun et al., 2015), the
mutations involved in the ability of NS1 proteins to restrict
the induction of the host interferon response (Li et al., 2006;
Thulasi Raman and Zhou, 2016), the length of the NA stalk
(Zhou et al., 2009). However, most of these studies focused on
H5 subtype of influenza viruses, and the pathogenic mechanism
of H9N2 viruses for mammals is poorly understood. The
substitution PB2 E627K which has been shown to be a key
factor in the increased virulence of H5N1 AIVs to mammals
has also been observed in the adaption of H9N2 viruses in
mice (Zhang et al., 2011; Wang et al., 2012). However, Wang
et al. (2012) reported that although the E627K mutation on
its own enhanced replication and polymerase activity, it did
not significantly increase pathogenicity of H9N2 virus, and
only the combination of PB2 E627K and M147L could increase
the virulence of the H9N2 virus in mice. Another report
also showed that a H9N2 virus containing a human-like PB2
segment with 627 K is non-pathogenic for mice, while the
mutation F404L in the PB2 segment could increase the virulence
of the H9N2 virus and the combination of PB2 F404L with
mutations in PA (D3V and S225R) and HA (L80F and N193D)
was able to make the non-pathogenic H9N2 virus become
high pathogenic for mice (Liu et al., 2015). However, it is still
unknown that if H9N2 virus could acquire the mutations that
govern the high pathogenicity for mice in natural, especially in
poultry.
In this study, we characterized two H9N2 AIVs, NJ06 and
NJ01, that were isolated from ducks in China. The NJ06
virus was highly pathogenic for mice and induced severe lung
lesions and excessive cytokine responses, while the NJ01virus
exhibited low pathogenicity in this model. However, there
were only twelve amino acid differences between the two
viruses, which might contribute to the high virulence of the
NJ06 virus in mice. Therefore, the two viruses had similar
genetic background, but showed different pathogenicity for mice,
which offer an appropriate system in which to explore the
molecular basis of host adaptation and enhanced virulence in
mammals.
MATERIALS AND METHODS
Ethics Statements
All animal experiments were approved by the Committee
on the Ethics of Animal Experiments of Jiangsu Academy
of Agricultural Sciences (JAAS no. 20141107), and complied
with the guidelines of Jiangsu Province Animal Regulations
(Government Decree No. 45). All experiments involving live
viruses and animals were carried out in negative pressure
isolators with HEPA filters in a biosafety level 2+ laboratory
(enhanced animal biosafety level 2 laboratory and a negative
pressure-ventilation laboratory) in accordance with the
institutional biosafety manual.
Viruses and Cells
The H9N2 viruses A/duck/Nanjing/06/2003 (NJ06) and
A/duck/Nanjing/01/1999 (NJ01) were isolated from ducks
in Jiangsu, China and propagated in specific pathogen-free
(SPF) embryonated chicken eggs. Viral titers were measured by
calculating the EID50. Madin–Darby canine kidney (MDCK)
cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 5% fetal bovine serum.
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Mouse Studies
Female BALB/c mice (5 weeks old) were used in this study. To
evaluate the virulence of the NJ06 and NJ01 viruses, groups of five
BALB/c mice were anesthetized with pentobarbital natricum and
inoculated intranasally with 10-fold serial dilutions of viruses in
30 µl PBS or mock inoculated with PBS to serve as controls. Body
weight and survival of mice were recorded daily for 14 days. Mice
that showed severe symptoms or lost more than 25% of their body
weight were euthanized and scored as dead for humane reasons.
The MLD50 of virus was calculated and expressed in EID50.
To evaluate viral replication in mice, groups of female BALB/c
mice were intranasally inoculated with 105 EID50 of the NJ01 and
NJ06 viruses, respectively. At 1, 2, 3, and 5 days post inoculation
(dpi), five mice in each group were euthanized, and whole lungs
were removed and homogenized in 1 ml of PBS for virus titration
in 10-day-old embryonated eggs as previously described (Hu
et al., 2013).
To assess lung injury, groups of five BALB/c mice were
intranasally inoculated with 105 EID50 of the NJ01 and NJ06
viruses, respectively, and lung histopathology and water content
were determined at 5 dpi. For histopathological analysis, mouse
lungs were fixed in 4% paraformaldehyde, embedded in paraffin,
cut into 5 mm-thick sections and then stained with haematoxylin
and eosin (H&E) for light microscopy. For water content analysis,
mouse lungs were surgically dissected, blotted dry, and weighed
immediately as wet weight, and then dried in an oven at 80◦C
for 72 h and reweighed as dry weight. The lung wet/dry weight
ratios were calculated for each animal to assess tissue edema as
previously described (Lang et al., 2005).
Growth Properties In vitro
To evaluate the replication of virus in vitro, MDCK or A549 cell
monolayer in 12-well plates were washed three times with PBS,
and inoculated at a multiplicity of infection of 0.01, overlaid with
serum-free DMEM containing 2 mg/ml TPCK-trypsin (Sigma–
Aldrich). Virus titers in supernatants were determined as the
number of 50% tissue culture infectious doses (TCID50) per ml
in MDCK cells at 12, 24, 48, and 72 h post inoculation (hpi).
Differential Leukocyte Counts and
Cytokine Expression Analysis
Inflammatory response in mouse lungs was assessed by testing
differential leukocyte counts in bronchoalveolar lavage (BAL)
fluid and expression profiles of representative cytokine genes of
mice infected with 105 EID50 of the NJ06 or NJ01 virus at the
indicated days. To determine differential leukocyte counts, BAL
cells were obtained from mouse lungs in each group as described
by Nick et al. (2000) and Densmore et al. (2013). In brief, the
lungs were lavaged twice with a total 1 ml saline (4◦C) through
the endotracheal tube, and the recovery rate of BAL fluid was not
less than 90% for each animal tested. After the amount of fluid
recovered was recorded, an aliquot of BAL fluid was diluted 1:1
with 0.01% crystal violet dye and 2.7% acetic acid for leukocyte
staining and erythrocyte hemolysis, and the number of leukocytes
in BAL fluid was counted with a haemocytometer under a light
microscope. Subsequently, the remaining fluid was centrifuged
for 10 min at 300× g. Cell differential counts were determined by
Wright staining of a spun sample, on the basis of morphological
criteria under a light microscope with evaluation of at least 200
cells per slide, and each slide was counted twice by different
observers blinded to the status of the animal.
Quantitative real-time PCR (qRT-PCR) was used to analyze
the expression of cytokine genes in mouse lungs. Total RNA was
isolated from lungs using TRIzol reagent (Life Technologies)
and treated with DNase I (Fermentas, Glen Burnie, MD, USA).
One microgram of total RNA per sample was reverse transcribed
into cDNA using a PrimeScript RT Reagent Kit (Takara). The
cDNA was run in the ABI 7500 Real Time PCR System using
an SYBR Premix Ex Taq Kit (Takara). One cycle for melting
curve analysis for all reactions was added to verify product
specificity. The expression of each cytokine gene relative to that
of the β-actin was calculated using the 2−11CT method. The
primers for TNF-α, CXCL10, IL-17a, and IL-10 were designed
based on these target mouse genes with GenBank accession
numbers NM_013693.3, NM_021274.2, NM_010552.3, and
NM_010548.2, respectively. The primers for β-actin have been
described previously (Hu et al., 2013). Primers for theses target
genes were as follows (forward and reverse primers, respectively):
for TNF-α, 5′-GCCAGGAGGGAGAACAGAAACTC-3′ and
5′-GGCCAGTGAGTGAAAGGGACA-3′; for CXCL10, 5′-ATC
CGGAATCTAAGACCATCAAGAA-3′ and 5′-TGTCCATCCAT
CGCAGCAC-3′; for IL-17a, 5′-GAAGG CCCTCAGACTA
CCTCAA-3′ and 5′-TCATGTGGTGGTCCAGCTTTC-3′; for
IL-10, 5′-GCCAGAGCCACATGCTCCTA-3′ and 5′-GATAA
GGCTTGGCAACCCAAGTAA-3′; and for β-actin, 5′-CATCCG
TAAAGACCTCTATGCCAAC-3′ and 5′-ATGGAGCCACCG
ATCCACA-3′.
Sequence Analysis
Viral RNA was extracted from infected allantoic fluid using
the Body Fluid Viral DNA/RNA Kit (Axygen) according to the
manufacture’s protocol. Reverse transcription was performed
using the Uni12-primer (5′-AGCAAAAGCAGG-3′) by standard
methods, and PCR amplification of cDNA was directed with
previously described primers (Hoffmann et al., 2001). PCR
products were purified using a DNA Gel Extraction Kit (Axygen)
in accordance with manufacture’s recommendations, and cloned
into the pMD-18T vector (Takara), and sent for commercial
sequence analysis (Sangon Biotechnology, Shanghai, China).
Sequencing results were phylogenetically analyzed with the
representative strains available in GenBank. The nucleotide
sequences were initially aligned using the Clustal V alignment
algorithm of the Megalign program (DNAStar, Madison, WI,
USA). The phylogenetic tree was constructed using MEGA
6.06 software with the neighbor-joining method. The GenBank
accession numbers for theNJ01 segments are KX349960,
KX349961, DQ681205, and DQ681221 to DQ681225, and those
for the NJ06 segments are KX349952 to KX349959.
Statistical Analysis
Data were analyzed using the SPSS Statistics software and
results were expressed as means ± standard deviation (SD).
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The statistical significance of differences was determined by an
independent-sample t-test.
RESULTS
Pathogenicity of NJ01 and NJ06 Viruses
in Mice
To compare the virulence of NJ06 with that of NJ01 virus,
MLD50 was determined. The results showed that NJ06 owned
an MLD50 of 102.83 EID50 and was highly pathogenic for mice
based on MLD50 values of <103.0 EID50 (Katz et al., 2000; Chen
et al., 2004), while NJ01 was low pathogenicity in mice, with
an MLD50 of >106.81 EID50. The morbidity and mortality of
the two viruses were also compared in mice in another study.
NJ06-infected mice showed obvious signs of illness, including
decreased activity, huddling, ruﬄed fur, heavy/labored breathing,
and hunched posture. Mice in this group began to lose weight at
1 dpi with a high inoculated dose of 106.0 EID50, and at 3 dpi with
a low inoculated dose of 103.0 EID50 (Figure 1A). In addition, all
of the mice in the NJ06-infected group showed obvious weight
loss and died by 5 dpi at a dose of 106.0 EID50, and by 10 dpi
at a dose of 104.0 EID50 (Figure 1B). In contrast, no mortality
was observed in NJ01-infected mice (Figure 1D), and the mice in
this group displayed only slight weight reduction throughout the
course of infection, and started to gain weight at 5 dpi, even at a
high dose of 106.0 EID50 (Figure 1C).
Replication of NJ06 and NJ01 Viruses In
vivo and In vitro
To determine whether the differences in virulence of NI06 and
NJ01 were related to the differences of viral replication in mice,
the levels of viral replication in mouse organs were compared.
No infectious virus was detected in the heart, liver, spleen, kidney,
brain from any of the NJ06- or NJ01-infected mice, whereas both
the two viruses replicated well in mouse lungs. However, the NJ06
virus replicated to a high titer that was 101.4-fold higher than the
NJ01 virus as early as 1 dpi and sustained significantly higher
levels of replication than the NJ01 virus throughout the course
of infection (Figure 2A). The NJ06 virus reached a peak titer of
107.4 EID50/ml at 3 dpi, versus a peak titer of 104.9 EID50/ml at
this time point for NJ01. Therefore, the NJ06 virus grew faster
and to significantly higher titers than the NJ01 virus, though the
two viruses all could replicate in mouse lungs.
The replication kinetics of the two viruses in vitro was also
measured in MDCK and A549 cells. The NJ06 virus grew to
significantly higher titers than NJ01 in either MDCK or A549
cells at each time point (Figure 2B). The NJ06 virus reached a
peak titer of 107.8 TCID50/ml at 48 hpi in MDCK cells, which
was 102.6-fold higher than the peak titer of NJ01 at this time
FIGURE 1 | Pathogenicity of NJ06 and NJ01 viruses in mice. Groups of five BALB/c mice were inoculated intranasally with different doses of virus (102–106
EID50 of NJ06 or 104–106 EID50 of NJ01) or mock inoculated (Mock). Morbidity was evaluated by monitoring weight changes over a 14-day period and is graphed
as a percentage of the animals’ weight on the day of inoculation (day 0). The average body weight of mice infected with NJ06 (A) or NJ01 (C) is shown. Mortality of
NJ06 (B) and NJ01 (D) infected mice was examined by measuring the percent survival.
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FIGURE 2 | Replication kinetics of NJ06 and NJ01viruses in vivo and in vitro. (A) Groups of three BALB/c mice were inoculated intranasally with 105 EID50 of
NJ06 or NJ01 viruses, and lungs were collected at for virus titration in eggs on the indicated days. (B) Madin–Darby canine kidney (MDCK) or A549 cells were
infected with NJ06 or NJ01 viruses at a multiplicity of infection of 0.01, and virus yields were determined in MDCK cells at appropriate time points. Data represent the
means of the results determined for three independent experiments ± standard deviations. ∗∗P < 0.01 compared with the value for the NJ01 virus.
point. The peak viral titer of NJ06 virus in A549 cells was also
observed on 48 hpi, reaching 107.2 TCID50/ml, versus virus titer
of 104.2 TCID50/ml at 48 hpi and reaching peak yield with 104.9
TCID50/ml at 72 hpi for NJ01. Therefore, the replication abilities
of NJ06 virus were significantly higher than the NJ01 virus both
in vivo and in vitro, which might correlate with the higher
virulence of NJ06 virus in mice.
Severe Lung Lesions in Mice Infected
with NJ06 Virus
To compare the lung lesions of mice infected with NJ06 or
NJ01, the gross and histopathologic changes in the mouse
lung was determined at 5 dpi, a time that immediately
preceded the death of mice infected with the NJ06 virus.
We found that NJ06-infected mice exhibited severe edema,
congestion, and hemorrhage in lungs (Figure 3A, right), whereas
the lung of NJ01-infected mice appeared normal except for
occasional small dark red foci of pneumonia (Figure 3A,
left). Moreover, the severe pulmonary edema in NJ06-infected
mice was further confirmed by the lung wet/dry weight ratios
(Figure 3B). Histologically, NJ06 induced severe pneumonia with
inflammatory cellular infiltration and hemorrhage, alveolar wall
edema and thickening, and deciduous epithelium mucosae and
inflammatory cells in the bronchioles (Figures 3C,D). However,
only mild and limited alveolitis was observed in the lungs of
NJ01-infected mice (Figures 3E,F).
Increased Numbers of BAL Cells in Mice
Infected with NJ06 Virus
To better characterize the inflammatory cellular components
in lungs, total and differential cell counts in BAL fluid
were determined at 5 dpi for NJ06- and NJ01-infected mice,
respectively. The total number of BAL cells was markedly
increased in mice infected with NJ06 virus compared to the NJ01
virus or mock infection group (Figure 4A). By contrast, there
were no statistically significant differences in the total numbers
of BAL cells between the NJ01 and mock infection groups. In
addition, cellular infiltration in the BAL samples during NJ06
virus infection was associated with an increase in the percentage
of neutrophils and lymphocytes compared with that for NJ01-
infected mice (Figures 4B–D). These data suggested that NJ06
virus induced a much larger increase of inflammatory cell
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FIGURE 3 | Lung lesions in mice. Groups of BALB/c mice were intranasally inoculated with 105 EID50 of the NJ06 and NJ01 viruses, respectively, gross pathology,
water content, and histopathology of lungs were determined at 5 days post inoculation (dpi). (A) Gross pathology of H9N2virus-infected lung. Severe edema,
congestion, and hemorrhage were observed in NJ06-infected lung (left), and the NJ01-infected lung (right) appeared normal except for occasional small dark red
foci. (B) Lung wet/dry weight ratios of H9N2 virus-infected mice. Data represent the means of the results determined for three independent experiments ± standard
deviations. ∗∗ indicates p < 0.01 compared with the mock group. (C,D) Representative histopathological changes in NJ01-infected lungs (H&E-stained). Only mild
and limited alveolitis was observed. (E,F) Representative histopathological changes in NJ06-infected lungs. Solid arrows indicate inflammatory cell infiltrates around
the bronchus, open arrows indicate edema and thickening of alveolar walls, Solid arrowheads indicate desquamation of epithelial cells in bronchial lumens.
infiltrate into the lungs, especially neutrophils and lymphocytes,
which may be contributing to the pathogenesis of the severe lung
injury associated with NJ06 virus infection.
NJ06 Virus Elicits Significantly High
Levels of Cytokine Response in Mouse
Lungs
To determine whether the different levels of virulence of NJ06
and NJ01 viruses were related to difference in cytokine expression
levels induced by the two viruses in mice, lungs from mice
infected with 105 EID50 of NJ06 or NJ01 virus were collected,
and subsequently assayed for TNF-α, CXCL10, IL-17a, and IL-
10 levels by qRT-PCR, respectively. The levels of all cytokines
were substantially greater than constitutive levels in the lungs
of NJ06- or NJ01-infected mice by 1 dpi (Figure 5). However,
NJ06 virus induced significantly higher levels of TNF-α and
CXCL 10 expression than did NJ01 at all time points. The IL-17a
was also detected at higher levels of expression in NJ06-infected
mice than in NJ01-infected mice, although the result at the early
time point, 1 dpi, was not significant. By contrast, at 1 dpi, the
levels of IL-10 were reduced in NJ06-infected mice compared
with those in NJ01-infected mice. Although the levels of IL-10
were elevated in NJ06-infected mice at 3 and 5 dpi, the latter
result was not significant compared with levels found in NJ01-
infected mice. In addition, a continuous increase in levels of
IL-10 was observed throughout the entire study period in NJ01-
infected mice, whereas the IL-10 levels in NJ06-infected mice
were reduced at the end of the observational period (5 dpi)
compared with the former time point (3 dpi). These data suggest
that the induction of inflammatory cytokines by NJ06 is different
from the induction by NJ06, which might contribute to the
observed differences in severity of disease caused by the two
viruses.
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FIGURE 4 | Total and differential cell counts in bronchoalveolar lavage (BAL) fluid. Groups of five mice were inoculated intranasally with 105 EID50 of NJ06 or
NJ01 virus, and BAL specimens were collected to determine cell counts on 5 dpi. The total numbers of BAL cells (A) and percentages of lymphocytes (B),
neutrophils, (C) and macrophages (D) of virus- or mock-inoculated mice are shown as means ± SD. ∗p < 0.05 and ∗∗p < 0.01.
Sequence and Phylogenetic Analysis
To determine the molecular basis for the differences in
pathogenicity between the two viruses, the sequences of all of
eight segments of NJ06 were compared with those of NJ01 virus.
This revealed twelve amino acid differences between these two
viruses, which were mapped to PB2, PB1, PA, HA (H3 numbering
used throughout the text), NP, NA, and NS gene (Table 1).
Phylogenetic analysis of the HA genes showed that both viruses
belonged to the Ck/BJ/1/94-like lineage (Figure 6), with the same
R-S-S-R amino acid motif at the cleavage sites, a characteristic
of low pathogenic avian influenza virus (LPAIV) between HA1
and HA2 [4,34]. The NA and M genes of these two isolates also
belong to the Ck/BJ/1/94-like lineage (Supplementary Figure S1),
and both viruses had the same “marking” deletion of three
amino acids (positions 62–64) at the NA stalk region, as
previously described (9, 11, 15). The NS and ribonucleoprotein
(PB2, PB1, PA, and NP) complex genes of the two viruses fell
into the DK/HK/Y439/97-like and Ck/SH/F/98-like, respectively
(Supplementary Figure S1).
To find out whether the amino acids found at these
positions in NJ06 were present also in other natural H9N2
strains, we analyzed the H9N2 sequences deposited in the
Influenza Research Database (the National Institute of Allergy
and Infectious Diseases database1; Table 1). Most avian, swine,
and human isolates possess the same amino acid as NJ06 at
positions PB1-187 (R), HA-147 and -477 (K and Y), NP-277 and
-340 (P and D), NA-9 and -435 (A and R), and NS1-171(D). By
contrast, at positions PB2-149 and -627, PA-548 and -550, and
NP-127, most avian, swine, and human isolates share common
residues as NJ01 virus. In fact, only five and one avian isolates
share the same residues with the NJ06 virus at positions PB2-
627(K) and NP-127 (G), respectively, and no isolates was found to
contain the residues PB2-149T, and PA-548L and -550M as NJ06
virus. Therefore, the amino acids observed at these positions in
NJ06 were unique to this virus, which might contribute to the
high virulence of the NJ06 virus.
DISCUSSION
Although highly pathogenic avian influenza viruses (HPAIVs),
such as H5 and H7 viruses, have caused serious harm to
human health, some recent studies have suggested that LPAIVs,
especially H9N2 viruses, could jump to humans more easily (Wan
1http://www.fludb.org
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FIGURE 5 | Inflammatory cytokines response in mouse lungs. Groups of five mice were intranasally inoculated with 105 ELD50 of NJ06 or NJ01 virus, and the
expression of these cytokines, TNF-α, IL-1β, IL-8, and IL-10, was measured in the mouse lungs at the indicated times by Quantitative real-time PCR (qRT-PCR).
Each cytokine expression was normalized to the expression of β-actin, and is presented as the fold change relative to the level of the mock group. The mean fold
change of each group is shown, with error bars representing the SD. ∗ indicates p < 0.05 and ∗∗ indicates p < 0.01 compared with the NJ01 virus infection group.
and Perez, 2007; Long et al., 2015). H9N2 AIVs have repeatedly
infected humans and other mammals (Peiris et al., 1999; Yu et al.,
2011; Sun et al., 2013), such as pigs and dogs, and could cause
mild respiratory disease in humans (Guo et al., 1999; Peiris et al.,
1999). More seriously, some H9N2 AIVs isolates could replicate
efficiently in mice and ferrets without prior adaptation, and was
able to adapt to high pathogenicity in mice. All these facts indicate
that H9N2 AIVs have gradually acquired mutations that make
them more adapted to mammals including humans (Wan and
Perez, 2007; Kimble et al., 2011; Mok et al., 2011), posing a
significant threat to public health. Therefore, it is necessary to
investigate the pathogenesis of H9N2 AIVs in mammals.
Although the ferret is well established as an animal model to
study human influenza virus pathogenesis and transmission, no
animal model is perfect and the use of ferrets for influenza studies
has been limited by the lack of availability of inbred and specific
pathogen–free animals, and the corresponding immunological
reagents (Oh and Hurt, 2016). Therefore, the mouse, another
commonly used model in influenza virus research (Belser and
Tumpey, 2013; Cauldwell et al., 2014; Thangavel and Bouvier,
2014), was used to compared the pathogenicity of the two
genetically similar H9N2 viruses in this study. We found that
the NJ06 virus was highly pathogenic for mice, while the NJ01
virus exhibited low pathogenicity in this animal model. The NJ06
virus caused signs of severe disease and resulted in 60% mortality
at a low inoculation dose of 103 EID50, whereas infection with
the DK1 virus did not cause death or obvious clinical signs of
illness even at a high dose of 106 EID50. Previous studies showed
that the high virulence of H5N1 AIVs for mice is associated
with the enhanced replication and extra-pulmonary infection
(Sirinonthanawech et al., 2011; Hu et al., 2013). Here, the NJ06
virus grew faster and to significantly higher titers in mouse lungs
than NJ01 virus, but both the two viruses were not able to spread
to the extra-pulmonary organs. These data support the viewpoint
that high replication ability replication in lungs is an important
and characteristic prerequisite for high virulence of AIV in mice.
Severe lung lesions characterized by massive edema, diffuse
alveolar damage, and excessive inflammatory cell infiltration
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are involved in the severe influenza in humans and animal
models caused by avian viruses, such as H5N1 and H7N9,
or highly pathogenic human viruses, such as the 1918 H1N1
virus (Gambotto et al., 2008; Franco-Paredes et al., 2009;
Uyeki, 2009; Zheng et al., 2013; Feng et al., 2014; Li et al.,
2014; Hrincius et al., 2015). Our results showed that the NJ06
infection could result in severe edema and alveolar damage, and
elevated inflammatory cell infiltration in mouse lungs, whereas
no difference in lung water content was observed between the
NJ01-infected group and the control group, and only mild
and limited alveolitis was observed in the NJ01-infected lungs.
In addition, the NJ06 infection resulted in significantly higher
numbers of inflammatory cells in BAL than NJ01 or mock
infection. Furthermore, the percentages of neutrophils in BAL
cells in NJ06-infected mice were significantly higher than those
in NJ01-infected mice. Neutrophils are primary mediator/effector
cells involved in producing acute lung injury (Headley et al., 1997;
Ayala et al., 2002), and the elevated levels of neutrophils have
also been found in the BAL samples of mice infected with highly
pathogenic H5N1 viruses or the novel H7N9 viruses (Xu et al.,
2009, 2013; Feng et al., 2015). Therefore, enhanced pulmonary
neutrophil invasion may be associated with the severity of NJ06
virus infection in mice.
It is generally accepted that dysregulation of cytokine
response is associated with the high virulence of AIVs in
mammals (Us, 2008). As expected, the NJ06 virus caused intense
expression of proinflammatory cytokine genes, such as TNF-
α, CXCL10, and IL-17a. TNF-α is a key factor modulating
neutrophil activity, and a high level of this cytokine has been
linked to the hyperresponsiveness of neutrophils (Grommes
and Soehnlein, 2011). CXCL10 is a potent chemoattractant for
activated Th1 lymphocytes and natural killer cells and plays
a role in the temporal development of innate and adaptive
immunity in concert with type I and II IFNs (Neville et al.,
1997). The high levels of TNF-α and CXCL10 have been
linked to the persistent severe viral disease in patients with
severe acute respiratory syndrome (Tobinick, 2004; de Jong
et al., 2006). IL-17a acts as a pro-inflammatory cytokine that
induces the expansion and accumulation of neutrophils of the
innate immune system (Perrone et al., 2008; Crowe et al.,
2009) and plays a critical role in mediating the acute lung
injury caused by 2009 pandemic H1N1 influenza infection
(Li et al., 2012). Therefore, based on the established role of
these cytokines in viral disease, our results suggest that these
pro-inflammatory cytokines may have pathological importance
in NJ06 infection and are partially responsible for disease
pathogenesis.
Although the NJ06 virus showed higher virulence and induced
more severe lung injury in mice compared with the NJ01virus,
the two viruses differed only by 12 amino acids distributed
throughout seven genes. Except for PB2-E627K, none of these
amino acid differences had been recognized to be related to
increased virulence or replication efficiency. The amino acid at
position 627 of PB2 is a well known determinant of host range,
and the substitution E627K has been shown to be crucial for the
adaptation and increased virulence of avian influenza viruses in
mammals (Subbarao et al., 1993; Hatta et al., 2001; Fornek et al.,
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FIGURE 6 | Phylogenetic tree of HA genes of representative H9N2 influenza A viruses. The tree was generated by the distance-based neighbor-joining
method using software MEGA 6.06. The reliability of the tree was assessed by bootstrap analysis with 1000 replicates. The viruses tested in this study are marked
with black triangle.
2009; Li et al., 2009). However, H5N1 isolates with PB2 627E
are also lethal to human (Mehle and Doudna, 2009) and mouse,
whereas H9N2 isolates with PB2 627K are not lethal for mouse
(Wang et al., 2012; Liu et al., 2014), indicating that the PB2 627K
is not a sole determinant factor for mammalian adaptation by
avian influenza viruses or its contribution to virulence need to
interact with residue at other positions or genes (Wang et al.,
2012; Liu et al., 2015). In addition, all other ten differences, except
for NA-K435R, were located in the recognized functional regions
that are involved in interaction of viral proteins or between the
virus and host factors. The HA-E157K residues locate to the
antigenic site I of the H9 HA corresponding to site B in H3 HA
(Both et al., 1983; Kaverin et al., 2004), and the NA-T9A residues
located in the amino-terminal transmembrane domain (Shtyrya
et al., 2009). The NS-N171D residues resides in the host cleavage
and polyadenylation factor (CPSF30) binding domain (Nemeroff
et al., 1998), which has been found to be associated with the
inhibition of 3′-end processing of cellular pre-mRNAs, including
IFN-β pre-mRNA (Noah et al., 2003). Seven different residues
(PB2-P149T, PB2-E627K, PB1-K187R, PA-M548L, PA-L550M,
NP-E127G, NP-H277P, and NP-N340D) in the RNP complexes
were all located in the known functional regions, including the
NP binding domain of the PB2 protein, the nuclear localization
sequence (NLS) of the PB1 protein, the PB1 binding domain of
the PA protein, and the PB2 binding regions of the NP protein
(Liu et al., 2009; Ng et al., 2009; Boivin et al., 2010; Ping et al.,
2011). Therefore, besides PB2 E627K, other residue differences
may also be associated with the high virulence of the NJ06
virus.
In summary, our study showed that a natural H9N2 isolate
is highly pathogenic for mice, which might suggest the potential
threat of H9N2 AIVs for other mammals, including humans,
and also highlight the necessity for continued evaluation of the
viral pathogenicity for mammals in the surveillance for LPAIVs,
especially H9N2 viruses. In addition, comparison of the predicted
amino acid sequences of NJ06 and NJ01 viruses showed that
twelve residues differences in specific functional regions of viral
genome resulted in the highly pathogenic phenotypes of the
NJ06 virus, including rapid growth in vivo and in vitro, severe
pulmonary lesions, excessive inflammatory cellular infiltration
and cytokine response in lungs, and death in mice. However,
it is not yet known which residues differences, or combinations
of differences, are responsible for the high virulence for mice.
We are currently attempting to determine the role of individual
mutations in the viruses’ pathogenicity in mice using a reverse
genetics approach.
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